Stocks

Headlines

Top Three Stocks to Consider Before Year End 2024

Investors are eyeing three compelling stocks to buy ahead of 2024's end. Despite recent price declines, The Coca-Cola Company, Uber Technologies, and Iovance Biotherapeutics present interesting opportunities for growth-driven investors, as detailed in a recent report.

Date: 
AI Rating:   6

The report highlights three stocks that may be worth considering: The Coca-Cola Company, Uber Technologies, and Iovance Biotherapeutics. Each of these companies is currently experiencing a decline in stock price from their respective highs, which creates a potential buying opportunity for investors.

The Coca-Cola Company (NYSE: KO) has seen its stock price drop 14% from its peak in September, attributed to a 1% decrease in cases sold. This decline may indicate challenges in revenue growth; however, Coca-Cola has a long-standing history of dividend growth, having increased its annual dividend for 62 years. The stock remains a reliable earnings generator in the consumer goods sector.

Uber Technologies (NYSE: UBER) reported revenue growth of 13% year over year, amounting to $11.2 billion, with analysts predicting a 17% growth for this year. A notable point is that Uber's earnings per share (EPS) are expected to rise from $0.87 to $1.89 this year, further climbing to $2.31 next year. This profitability trend bodes well for the stock's outlook.

Iovance Biotherapeutics (NASDAQ: IOVA), while less established, is expected to see significant revenue growth from its drug, Amtagvi. The projected revenue for the fiscal year ending this month is between $160 million and $165 million, potentially increasing to $450 million to $475 million next year. While still not profitable, the firm has ambitious plans that suggest it could swing to profitability by 2027.

In summary, Coca-Cola is struggling but maintains a strong dividend record, Uber is demonstrating solid revenue and EPS growth, and while Iovance is still losing money, it has promising growth prospects. Each stock's current dip in price provides a potential entry point for investors looking for growth opportunities.